Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

City Therapeutics, Inc.

NASDAQ: CTY · Life Sciences · 4 alerts · CIK 2143850

Share price
$16.98Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All City Therapeutics, Inc. filings on SEC EDGAR ↗

7:07 AM ET 8-K
Business Update

City Therapeutics Business Update

City Therapeutics announced the first participant has been dosed in its Phase 1 clinical trial of CITY-RBP4 for the treatment of Stargardt disease. The trial is a first-in-human study evaluating the safety, tolerability, and pharmacodynamics of the RNAi therapeutic candidate, with initial data expected in mid-2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.